Cyclo Therapeutics Reports Q2 Financials with Mixed Results: A Look into CYTH and HITI
Aug 15, 2024
Therapeutics Stock Market Invest
INHALE-3 Study Shows Positive Results for Inhaled Insulin in T1D Patients, Implications for MannKind Corporation
Jun 23, 2024
Neumora Therapeutics Initiates Phase 1b Trial for Novel Alzheimers Agitation Treatment
Jun 21, 2024
Dyne Therapeutics Announces Participation at Jefferies Global Healthcare Conference
May 30, 2024
MiNK Therapeutics Showcases AgenT-797's Clinical Efficacy in Transplant Patient with ARDS
May 23, 2024
XORTX Therapeutics Reports 2023 Milestones and Preps for Key Clinical Trial
Mar 19, 2024
Cognition Therapeutics Unveils Planned Public Offering of Common Stock
Mar 12, 2024
Pyxis Oncology Announces New Inducement Grants in Compliance with Nasdaq Rules
Dec 30, 2023